Skip to main content

Table 3 Subgroup analysis for the association between LAR and mortality

From: The LDL-C/ApoB ratio predicts cardiovascular and all-cause mortality in the general population

 

Cardiovascular mortality

All-cause mortality

N (%)

LAR

HR (95% CI)

P value

p-int

N (%)

LAR

HR (95% CI)

P value

p-int

Age

   

0.044

   

< 0.001

 <65 years

33 (0.3%)

0.496 (0.173, 1.425)

0.193

 

255 (2.6%)

0.686 (0.436, 1.080)

0.103

 

 ≥ 65 years

117 (4.5%)

0.071 (0.013, 0.395)

0.003

 

617 (23.5%)

0.164 (0.083, 0.325)

< 0.001

 

Gender

   

0.487

   

0.066

 Male

98 (1.6%)

0.209 (0.050, 0.877)

0.032

 

516 (8.6%)

0.282 (0.160, 0.498)

< 0.001

 

 Female

52 (0.8%)

0.382 (0.118, 1.238)

0.109

 

356 (5.6%)

0.545 (0.325, 0.912)

0.021

 

CAD

   

0.978

   

0.636

 Yes

35 (2.6%)

0.298 (0.055, 1.633)

0.163

 

190 (14.4%)

0.476 (0.223, 1.013)

0.054

 

 No

115 (1.0%)

0.306 (0.102, 0.922)

0.035

 

682 (6.1%)

0.389 (0.246, 0.615)

< 0.001

 

Diabetes

   

0.124

   

0.258

 Yes

48 (2.5%)

0.749 (0.165, 3.412)

0.709

 

312 (16.2%)

0.529 (0.287, 0.972)

0.040

 

 No

102 (1.0%)

0.187 (0.059, 0.593)

0.004

 

560 (5.3%)

0.346 (0.209, 0.572)

< 0.001

 

Lipid-lowering medication

   

0.843

   

0.116

 Yes

67 (2.5%)

0.275 (0.068, 1.117)

0.071

 

316 (11.9%)

0.602 (0.320, 1.133)

0.116

 

 No

83 (0.8%)

0.327 (0.097, 1.095)

0.070

 

556 (5.7%)

0.331 (0.204, 0.538)

< 0.001

 

Hypertriglyceridemia

   

0.064

   

0.355

 Yes

50 (1.6%)

0.814 (0.185, 3.586)

0.785

 

246 (8.0%)

0.545 (0.286, 1.039)

0.065

 

 No

100 (1.1%)

0.143 (0.044, 0.467)

0.001

 

626 (6.7%)

0.376 (0.231, 0.611)

< 0.001

 
  1. h Hazard ratio, CI Confidence interval, p-int p for interaction. Hypertriglyceridemia was defined as serum TG level > 1.7 mmol/L. Adjusted for age, sex, race, drinking, smoking, hypertension, diabetes, coronary artery disease, serum triglyceride level, and lipid-lowering drugs as required